Evidence map›Paper›PMID 39683939›Full record

ArticleMolecules (Basel, Switzerland)2024

A Chemiluminescence Signal Amplification Method for MicroRNA Detection: The Combination of Molecular Aptamer Beacons with Enzyme-Free Hybridization Chain Reaction.

Yu Han, Jialin Li, Man Li, Ran An, Xu Zhang, Sheng Cai

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yu HanCollege of Pharmacy, Jilin Medical University, Jilin 132013, China.ORCID 0000-0002-2390-6257
Jialin LiCollege of Pharmacy, Jilin Medical University, Jilin 132013, China.
Man LiCollege of Pharmacy, Jilin Medical University, Jilin 132013, China.
Ran AnCollege of Pharmacy, Jilin Medical University, Jilin 132013, China.
Xu ZhangCollege of Pharmacy, Jilin Medical University, Jilin 132013, China.
Sheng CaiInstitute of Drug Metabolism and Pharmaceutical Analysis, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, Zhejiang University, Hangzhou 310058, China.ORCID 0000-0002-0876-0050

Funding

Jilin Medical University JYBS2023005LKJilin Province Antibody Engineering Science and Technology Collaborative Innovation Center S202413706029the Science and Technology Research Project of Education Department of Jilin Province of China JJKH20240594KJ
6 · The paper itself

Abstract

The association between microRNA (miRNA) and various diseases has been established; miRNAs have the potential to be biomarkers for these diseases. Nevertheless, the challenge of correctly quantifying an miRNA arises from its low abundance and a high degree of family homology. Therefore, in the present study, we devised a chemiluminescence (CL) detection method for miRNAs, known as the hybridization chain reaction (HCR)-CL, utilizing the enzyme-free signal amplification technology of HCR. The proposed methodology obviates the need for temperature conversion and offers a straightforward procedure owing to the absence of enzymatic participation, and the lumino-H

Indexed as

Aptamers, NucleotideLuminescent MeasurementsMicroRNAsNucleic Acid HybridizationBiosensing TechniquesHumansHydrogen PeroxideLuminescenceAptamers, NucleotideHydrogen PeroxideMicroRNAschemiluminescencehybridization chain reactionmiR-146bmolecular aptamer beacon

Identifiers

PMID39683939
PMCPMC11643668

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.